Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ADTX

Aditxt (ADTX)

Aditxt Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADTX
DateTimeSourceHeadlineSymbolCompany
08/14/20244:15PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ADTXAditxt Inc
08/14/20247:00AMPR Newswire (US)Evofem Biosciences Announces Financial Results for the Second Quarter of 2024NASDAQ:ADTXAditxt Inc
08/13/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
08/13/20248:15AMBusiness WireAditxt Announces the Successful Passage of all Proposals at Recent Annual Shareholders’ Meeting, Setting the Stage for 2024 and 2025 Strategic PlansNASDAQ:ADTXAditxt Inc
08/09/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
08/09/20244:15PMBusiness WireAditxt Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
08/09/202410:28AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ADTXAditxt Inc
08/09/20248:00AMBusiness WireAditxt Announces $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
08/08/20249:44AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
08/08/20247:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
08/07/20243:25PMAllPennyStocks.comBiotech Soars Despite Broader SelloffNASDAQ:ADTXAditxt Inc
08/07/20248:15AMBusiness WireAditxt Subsidiary Pearsanta Seeks Clinical Trial Translational Endpoints Research Award for Early Detection of Ovarian CancerNASDAQ:ADTXAditxt Inc
08/07/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADTXAditxt Inc
08/01/20244:15PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ADTXAditxt Inc
08/01/20244:15PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ADTXAditxt Inc
07/25/20249:00AMGlobeNewswire Inc.Evofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1stNASDAQ:ADTXAditxt Inc
07/25/20248:30AMBusiness WireAditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the AcquisitionNASDAQ:ADTXAditxt Inc
07/23/20248:47AMPR Newswire (US)Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1NASDAQ:ADTXAditxt Inc
07/22/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
07/18/20244:17PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ADTXAditxt Inc
07/18/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
07/17/20246:30AMBusiness WireAditxt and Evofem Amend and Restate Merger Agreement, Targeting September 30 ClosingNASDAQ:ADTXAditxt Inc
07/11/20244:30PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ADTXAditxt Inc
07/09/20245:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
07/08/20246:25AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
06/27/20248:36AMPR Newswire (US)Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's HealthcareNASDAQ:ADTXAditxt Inc
06/14/20244:01PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ADTXAditxt Inc
06/12/20244:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
06/07/20245:12PMEdgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:ADTXAditxt Inc
05/29/20244:33PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ADTXAditxt Inc
 Showing the most relevant articles for your search:NASDAQ:ADTX